Aisling Capital related stories
All articles and analysis
AxioMed Spine Further Funded by Ohio Loan--CORRECTEDAxioMed Spine, which manufactures artificial disc replacements for medical patients, received $500,000 in the form of a loan from the state of Ohio to continue developing an artificial cervical spine disc. The company has raised $56 million to date from investors including Siemens Venture Capital GmbH, Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and OrbiMed Advisors.
- NextWave Pharmaceuticals Secures $45 Million in Financing
NextWave Pharmaceuticals Inc. secured $45 million in a Series C financing, which was co-led by new investors Panorama Capital o Menlo Park, Calif., and Bay City Capital LLC of San Francisco, Calif. Kearny Venture Partners and current investors: Aisling Capital, Fidelity Biosciences, Sofinnova Ventures and Vivo Ventures participated in the round. NextWave plans to use the capital to commercialize its NEXICLON™ XR product for the treatment of hypertension, to expand the CNS portfolio and to prepare for introduction of a novel extended-release liquid methylphenidate for Attention Deficit Hyperactivity Disorder.
- Durata Therapeutics Forms A Senior Leadership Team
Durata Therapeutics Inc. formed a senior leadership team. It named Paul R. Edick as chief executive officer, Corey N. Fishman as chief operating officer and Michael Dunne as chief medical officer. Durata is a Morristown, N.J.-based biopharmaceutical company that is backed by Aisling Capital, Canaan Partners, Domain Associates LLC, New Leaf Venture Partners LLC and Sofinnova Ventures Inc.
- ViewRay Raises $20 Million
ViewRay Inc., a Cleveland-based developer of image-guided radiation therapy systems, has raised $20 million in Series C funding. Siemens Venture Capital led the round, and was joined by Fidelity Biosciences, Kearny Venture Partners and OrbiMed Advisors.
- Week in deals, Aug. 16, 2010
Summary of tech companies and other startups in North America that raised venture financing in the past week
- CeNeRx BioPharma Raises $13 Million
CeNeRx BioPharma Inc., a Cary, N.C.-based developer of CNS drugs, has raised $13 million in new Series C funding (including $3m in debt). Return backers include Aisling Capital, L Capital Partners and Pappas Ventures.
- peHUB Wire: Friday, August 13, 2010
Random Ramblings
- peHUB Wire: Friday, August 13, 2010
Random Ramblings
- Investors in eye-related companies focus on exits
”LensX Lasers, bought for more than $361M in cash, the latest eye company to be bought